FIV-based lentiviral vector gene therapy (University of Iowa)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFIV-based lentiviral vector gene therapy (University of Iowa)
Drug Alias Namefeline immunodeficiency virus-based lentiviral vector gene therapy (University of Iowa)gene therapy (University of Iowa)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsMucopolysaccharidosesHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Iowa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Iowa
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidosesHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A